Skip to content

Effect of Triticale, Mung Bean and Adzuki Bean Intervention on Patients With Type 2 Diabetes

Effect of Triticale, Mung Bean and Adzuki Bean Intervention on Metabolic and Nutritional Status of Patients With Type 2 Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02999867
Enrollment
180
Registered
2016-12-21
Start date
2017-03-01
Completion date
2017-07-30
Last updated
2018-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 Diabetes Mellitus

Brief summary

This study is designed to evaluate short term effect of triticale, mung bean and adzuki bean intervention for health improvement in patients with type 2 diabetes.

Detailed description

The study will evaluate the effect of triticale, mung bean and adzuki bean on metabolic and nutritional status of patients with type 2 diabetes after 30 days of intervention. Patients will be assigned to control or intervention group (A diet including triticale and mung bean; B diet including adzuki bean). Blood and urine samples will be collected at baseline and after 30 days of intervention.

Interventions

DIETARY_SUPPLEMENTtriticale and mung bean

subjects are assigned to intake of triticale and mung bean for 30 days

DIETARY_SUPPLEMENTadzuki bean

subjects are assigned to intake of adzuki bean for 30 days

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Male and female patients between the ages of 30 and 65 years 2. patients has been diagnosed as type 2 diabetes mellitus 3. Patients who like to be followed up for 2 months.

Exclusion criteria

1. Women in pregnancy or lactation. 2. Individuals with a history of severe kidney disease, cardiovascular disease, stroke, cancer, or psychological disorders.

Design outcomes

Primary

MeasureTime frame
response to the dietary intervention by the change from baseline in blood glucose at 30-daybaseline and 30 d
response to the dietary intervention by the change from baseline in lipid profile at 30-daybaseline and 30 d
response to the dietary intervention by the change from baseline in insulin resistance at 30-daybaseline and 30 d

Secondary

MeasureTime frame
response to the dietary intervention by the change from baseline in folic acid absorption at 30-daybaseline and 30 d
response to the dietary intervention by the change from baseline in renal function at 30-daybaseline and 30 d
response to the dietary intervention by the change from baseline in iron absorption at 30-daybaseline and 30 d
response to the dietary intervention by the change from baseline in liver function at 30-daybaseline and 30 d
response to the dietary intervention by the change from baseline in inflammation result at 30-daybaseline and 30 d

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026